Literature DB >> 27648893

An Update on Existing Ongoing Prospective Trials Evaluating the Effect of Anesthetic and Analgesic Techniques During Primary Cancer Surgery on Cancer Recurrence or Metastasis.

Jonathan Royds1, Abdul H Khan, Donal J Buggy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27648893     DOI: 10.1097/AIA.0000000000000123

Source DB:  PubMed          Journal:  Int Anesthesiol Clin        ISSN: 0020-5907


× No keyword cloud information.
  6 in total

1.  Suppression of Human Natural Killer Cells by Different Classes of Opioids.

Authors:  Dermot P Maher; Deepa Walia; Nicola M Heller
Journal:  Anesth Analg       Date:  2019-05       Impact factor: 5.108

Review 2.  Effect of Propofol on breast Cancer cell, the immune system, and patient outcome.

Authors:  Ru Li; Hengrui Liu; James P Dilger; Jun Lin
Journal:  BMC Anesthesiol       Date:  2018-06-26       Impact factor: 2.217

3.  Effects of local anesthetics on breast cancer cell viability and migration.

Authors:  Ru Li; Chunyun Xiao; Hengrui Liu; Yujie Huang; James P Dilger; Jun Lin
Journal:  BMC Cancer       Date:  2018-06-19       Impact factor: 4.430

4.  Enhanced Antitumor Activity of Lidocaine Nanoparticles Encapsulated by a Self-Assembling Peptide.

Authors:  Yang Yang; Jiaxiao Sun; Fei Peng; Haibei Liu; Guoyan Zhao; Junjie Chen; Wensheng Zhang; Feng Qiu
Journal:  Front Pharmacol       Date:  2022-04-21       Impact factor: 5.988

5.  Levobupivacaine inhibits proliferation and promotes apoptosis of breast cancer cells by suppressing the PI3K/Akt/mTOR signalling pathway.

Authors:  Akosua Kotaa Kwakye; Sylvanus Kampo; Jiaxin Lv; Muhammad Noman Ramzan; Seidu A Richard; Aglais Arredondo Falagán; Jerry Agudogo; Evans Atito-Narh; Qiu Yan; Qing-Ping Wen
Journal:  BMC Res Notes       Date:  2020-08-17

Review 6.  TRPM7 Ion Channel: Oncogenic Roles and Therapeutic Potential in Breast Cancer.

Authors:  Clément Cordier; Natalia Prevarskaya; V'yacheslav Lehen'kyi
Journal:  Cancers (Basel)       Date:  2021-12-16       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.